A polymorphism of the ABCA1 gene confers susceptibility to schizophrenia and related brain changes

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 8, 2011, Pages 1877-1883

  Ota, Miho ^a   Fujii, Takashi ^a   Nemoto, Kiyotaka ^b,c   Tatsumi, Masahiko ^d   Moriguchi, Yoshiya ^a   Hashimoto, Ryota ^a,e,f   Sato, Noriko ^c   Iwata, Nakao ^g,h   Kunugi, Hiroshi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d Yokohama Shinryo Clinic   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

ATP binding cassette transporter A1; Polymorphism; Schizophrenia; Voxel based morphometry

Indexed keywords

ABCA1 GENE; ADULT; ALLELE; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRAY MATTER; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ATP BINDING CASSETTE TRANSPORTER 1; BRAIN; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, UNMYELINATED; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEX FACTORS;

EID: 82455210783     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.07.012     Document Type: Article

References (53)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
2. Badenhop R.F., Moses M.J., Scimone A., Mitchell P.B., Ewen-White K.R., Rosso A., et al. A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19. Mol Psychiatry 2002, 7:851-859.
3. Barak V., Barak Y., Levine J., Nisman B., Roisman I. Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. J Basic Clin Physiol Pharmacol 1995, 6:61-69.
4. Bassett A.S., Chow E.W., O'Neill S., Brzustowicz L.M. Genetic insights into the neurodevelopmental hypothesis of schizophrenia. Schizophr Bull 2001, 27:417-430.
5. Buchsbaum M.S., Schoenknecht P., Torosjan Y., Newmark R., Chu K.W., Mitelman S., et al. Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Ann Gen Psychiatry 2006, 5:19.
6. Catalano G., Duchene E., Le Julia Z., Goff W., Bruckert E., Chapman M.J., et al. Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects. J Lipid Res 2008, 49:635-643.
7. Chen M., Li W., Wang N., Zhu Y., Wang X. ROS and NF-kappaB but not LXR mediate IL-1beta signaling for the downregulation of ATP-binding cassette transporter A1. Am J Physiol Cell Physiol 2007, 292:1493-1501.
8. Chen X., Sun C., Chen Q., O'Neill F.A., Walsh D., Fanous A.H., et al. Apoptotic engulfment pathway and schizophrenia. PLoS One 2009, 4:e6875.
9. Clee S.M., Zwinderman A.H., Engert J.C., Zwarts K.Y., Molhuizen H.O., Roomp K., et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 2001, 103:1198-1205.
10. Ellison-Wright I., Glahn D.C., Laird A.R., Thelen S.M., Bullmore E. The Anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008, 165:1015-1023.
11. Fornito A., Yücel M., Patti J., Wood S.J., Pantelis C. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 2009, 108:104-113.
12. Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 2004, 114:1343-1353.
13. Garver D.L., Holcomb J.A., Christensen J.D. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int J Neuropsychopharmacol 2008, 11:49-61.
14. Glahn D.C., Laird A.R., Ellison-Wright I., Thelen S.M., Robinson J.L., Lancaster J.L., et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 2008, 64:774-781.
15. Good C.D., Johnsrude I., Ashburner J., Henson R.N.A., Friston K.J., Frackowiak R.S.J. Cerebral asymmetry and the effect of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage 2001, 14:685-700.
16. Goritz C., Mauch D.H., Pfrieger F.W. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol Cell Neurosci 2005, 29:190-201.
17. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001, 98:4746-4751.
18. Honea R.A., Meyer-Lindenberg A., Hobbs K.B., Pezawas L., Mattay V.S., Egan M.F., et al. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry 2008, 63:465-474.
19. Huang T.L., Chen J.F. Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan. Schizophr Res 2005, 80:55-59.
20. Kanaan R.A., Kim J.S., Kaufmann W.E., Pearlson G.D., Barker G.J., McGuire P.K. Diffusion tensor imaging in schizophrenia. Biol Psychiatry 2005, 58:921-929.
21. Karasinska J.M., Rinninger F., Lütjohann D., Ruddle P., Franciosi S., Kruit J.K., et al. Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J Neurosci 2009, 29:3579-3589.
22. Katzov H., Chalmers K., Palmgren J., Andreasen N., Johansson B., Cairns N.J., et al. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 2004, 23:358-367.
23. Knight B.L. ATP-binding cassette transporter A1: regulation of cholesterol efflux. Biochem Soc Trans 2004, 32:124-127.
24. Koldamova R., Staufenbiel M., Lefterov I. Lack of ABCA1 considerably decreases brainAPOElevel and increases amyloid deposition in APP23 mice. J Biol Chem 2005, 280:43224-43235.
25. Konrad A., Winterer G. Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?. Schizophr Bull 2008, 34:72-92.
26. Kubicki M., McCarley R., Westin C.F., Park H.J., Maier S., Kikinis R., et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res 2007, 41:15-30.
27. Kuivenhoven J.A., Hovingh G.K., van Tol A., Jauhiainen M., Ehnholm C., Fruchart J.C., et al. Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size. Atherosclerosis 2003, 171:311-319.
28. Le Hellard S., Mühleisen T.W., Djurovic S., Fernø J., Ouriaghi Z., Mattheisen M., et al. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples. Mol Psychiatry 2010, 15:463-472.
29. Li J., Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005, 95:221-227.
30. Liu J., Juo S.H., Dewan A., Grunn A., Tong X., Brito M., et al. Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12. Mol Psychiatry 2003, 8:333-342.
31. Mata I., Perez-Iglesias R., Roiz-Santiañez R., Tordesillas-Gutierrez D., Gonzalez-Mandly A., Vazquez-Barquero J.L., et al. A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia. Biol Psychiatry 2009, 65:535-540.
32. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001, 294:1354-1357.
33. Moskvina V., Craddock N., Holmans P., Nikolov I., Pahwa J.S., Green E. Welcome Trust Case Control Consortium, Owen MJ, O'Donovan MC. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 2009, 14:252-260.
34. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004, 74:765-769.
35. Otsubo T., Tanaka K., Koda R., Shinoda J., Sano N., Tanaka S., et al. Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psychiatry Clin Neurosci 2005, 59:517-526.
36. Park N., Juo S.H., Cheng R., Liu J., Loth J.E., Lilliston B., et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry 2004, 9:1091-1099.
37. Saher G., Brugger B., Lappe-Siefke C., Mobius W., Tozawa R., Wehr M.C., et al. High cholesterol level is essential for myelin membrane growth. Nat Neurosci 2005, 8:468-475.
38. Sárvári M., Kalló I., Hrabovszky E., Solymosi N., Tóth K., Likó I., et al. Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-aged, ovariectomized rats. Endocrinology 2010, 151:3847-3862.
39. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(suppl. 20):22-57.
40. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr Res 2001, 49:1-52.
41. Shibata N., Kawarai T., Lee J.H., Lee H.S., Shibata E., Sato C., et al. Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci Lett 2006, 391:142-146.
42. Srivastava R.A. Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen. Mol Cell Biochem 2002, 240:67-73.
43. Sundar P.D., Feingold E., Minster R.L., DeKosky S.T., Kamboh M.I. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol Aging 2007, 28:856-862.
44. Thomas E.A., Dean B., Pavey G., Sutcliffe J.G. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci USA 2001, 98:4066-4071.
45. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
46. Tregouet D.A., Ricard S., Nicaud V., Arnould I., Soubigou S., Rosier M., et al. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol 2004, 24:775-781.
47. Valenza M., Rigamonti D., Goffredo D., Zuccato C., Fenu S., Jamot L., et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci 2005, 25:9932-9939.
48. Vance J.E., Hayashi H., Karten B. Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 2005, 16:193-212.
49. Venken T., Claes S., Sluijs S., Paterson A.D., van Duijn C., Adolfsson R., et al. Genomewide scan for affective disorder susceptibility Loci in families of a northern Swedish isolated population. Am J Hum Genet 2005, 76:237-248.
50. Wahrle S.E., Jiang H., Parsadanian M., Legleiter J., Han X., Fryer J.D., et al. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 2004, 279:40987-40993.
51. Wong J., Quinn C.M., Brown A.J. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem J 2006, 400:485-491.
52. Wright I.C., Rabe-Hesketh S., Woodruff P.W.R., David A.S., Murray R.M., Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000, 157:16-25.
53. Xu M., He L. Convergent evidence shows a positive association of interleukin-1 gene complex locus with susceptibility to schizophrenia in the Caucasian population. Schizophr Res 2010, 120:131-142.